Equities analysts expect Trupanion Inc (NASDAQ:TRUP) to report sales of $77.54 million for the current quarter, according to Zacks. Three analysts have issued estimates for Trupanion’s earnings, with the highest sales estimate coming in at $77.80 million and the lowest estimate coming in at $77.30 million. Trupanion posted sales of $63.12 million in the same quarter last year, which indicates a positive year over year growth rate of 22.8%. The company is scheduled to announce its next earnings report after the market closes on Thursday, November 8th.
According to Zacks, analysts expect that Trupanion will report full-year sales of $301.49 million for the current fiscal year, with estimates ranging from $300.10 million to $302.30 million. For the next fiscal year, analysts anticipate that the firm will report sales of $359.49 million, with estimates ranging from $349.40 million to $366.87 million. Zacks’ sales calculations are an average based on a survey of analysts that that provide coverage for Trupanion.
Trupanion (NASDAQ:TRUP) last released its quarterly earnings results on Thursday, August 2nd. The financial services provider reported ($0.01) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.05) by $0.04. The business had revenue of $73.39 million for the quarter, compared to analyst estimates of $72.70 million. Trupanion had a negative net margin of 0.84% and a negative return on equity of 4.43%. The firm’s revenue was up 25.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.02) earnings per share.
In related news, Director Murray B. Low sold 3,000 shares of the company’s stock in a transaction on Friday, August 10th. The shares were sold at an average price of $38.12, for a total transaction of $114,360.00. Following the completion of the sale, the director now directly owns 189,782 shares of the company’s stock, valued at approximately $7,234,489.84. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Darryl Rawlings sold 4,000 shares of the company’s stock in a transaction on Friday, October 12th. The stock was sold at an average price of $29.04, for a total transaction of $116,160.00. Following the sale, the insider now directly owns 1,277,989 shares of the company’s stock, valued at $37,112,800.56. The disclosure for this sale can be found here. Insiders sold 23,450 shares of company stock valued at $835,119 over the last three months. Insiders own 20.70% of the company’s stock.
Several hedge funds and other institutional investors have recently bought and sold shares of TRUP. Riverbridge Partners LLC bought a new stake in shares of Trupanion during the 2nd quarter worth $20,130,000. Morgan Stanley boosted its holdings in shares of Trupanion by 41.5% during the 2nd quarter. Morgan Stanley now owns 1,157,405 shares of the financial services provider’s stock worth $44,675,000 after buying an additional 339,550 shares during the period. BlackRock Inc. boosted its holdings in shares of Trupanion by 21.3% during the 2nd quarter. BlackRock Inc. now owns 1,619,838 shares of the financial services provider’s stock worth $62,525,000 after buying an additional 284,030 shares during the period. Columbus Circle Investors bought a new stake in Trupanion in the 2nd quarter valued at $8,776,000. Finally, Public Employees Retirement Association of Colorado bought a new stake in Trupanion in the 2nd quarter valued at $7,141,000. 93.37% of the stock is owned by institutional investors and hedge funds.
Trupanion stock traded up $0.49 during trading hours on Wednesday, hitting $26.03. The company had a trading volume of 4,532 shares, compared to its average volume of 492,990. The firm has a market cap of $847.74 million, a PE ratio of -374.29 and a beta of 0.60. The company has a debt-to-equity ratio of 0.16, a quick ratio of 3.04 and a current ratio of 3.04. Trupanion has a fifty-two week low of $24.37 and a fifty-two week high of $46.70.
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels.
Recommended Story: Diversification in Investing
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.